10.1016/j.compbiomed.2021.104560
10.1016/j.compbiomed.2021.104560 · doi-reference
10.1073/pnas.0805240105
10.1073/pnas.0805240105 · doi-reference
The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man
10.1080/10715769900301141 · doi-reference
10.1002/cbic.201500284
10.1002/cbic.201500284 · doi-reference
Elucidating the inhibitory effect of resveratrol and its structural analogs on selected nucleotide- related enzymes
10.3390/biom10091223 · doi-reference
Frangulosid as a novel hepatitis B virus DNA polymerase inhibitor: a virtual screening study
10.1007/s40203-018-0047-3 · doi-reference
Gram (−) microorganisms DNA polymerase inhibition, antibacterial and chemical properties of fruit and leaf extracts of Sorbus acuparia and Sorbus caucasica var. yaltirikii
10.1002/bmc.3901 · doi-reference
Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells
10.3892/ijo.2017.3886 · doi-reference
Polyphenols enhance the activity of alkylating agents in leukaemia cell lines
10.18632/oncotarget.27068 · doi-reference
10.1128/jvi.78.20.11334-11339.2004
10.1128/jvi.78.20.11334-11339.2004 · doi-reference
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
10.1016/j.antiviral.2006.04.014 · doi-reference
10.1080/14756366.2016.1265519
10.1080/14756366.2016.1265519 · doi-reference
10.1016/j.bmcl.2009.02.010
10.1016/j.bmcl.2009.02.010 · doi-reference
10.1016/j.bmcl.2009.07.009
10.1016/j.bmcl.2009.07.009 · doi-reference
10.1007/s12272-012-0108-9
10.1007/s12272-012-0108-9 · doi-reference
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
10.1016/j.antiviral.2005.02.007 · doi-reference
10.1016/j.jep.2008.03.018
10.1016/j.jep.2008.03.018 · doi-reference
Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds
10.1016/j.antiviral.2005.07.002 · doi-reference
Antiviral effects of saikosaponins on human coronavirus 229E in vitro
10.1111/j.1440-1681.2006.04415.x · doi-reference
10.1016/j.bmc.2010.09.035
10.1016/j.bmc.2010.09.035 · doi-reference
10.4103/2225-4110.124335
10.4103/2225-4110.124335 · doi-reference
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3′- digallate (TF3)
10.1093/ecam/neh081 · doi-reference
Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro
10.3851/imp1615 · doi-reference
10.1016/j.bmc.2013.03.027
10.1016/j.bmc.2013.03.027 · doi-reference
Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia
10.1016/j.antiviral.2015.08.010 · doi-reference
10.1128/jvi.03637-13
10.1128/jvi.03637-13 · doi-reference
10.1128/jvi.05869-11
10.1128/jvi.05869-11 · doi-reference
Resveratrol suppresses nuclear factor-B in herpes simplex virus infected cells
10.1016/j.antiviral.2006.06.011 · doi-reference
Resveratrol as a novel anti-herpes simplex virus nutraceutical agent: an overview
10.3390/v10090473 · doi-reference
Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle
10.3390/molecules15107115 · doi-reference
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt’s lymphoma cells by affecting multiple molecular targets
10.1016/j.antiviral.2012.09.003 · doi-reference
